Want to join the conversation?
$MYL, the biggest U.S. generic drug maker, said that with the Biocon partnership and Momenta collaboration, it now has a combined portfolio of 15 biosimilar and insulin analog generic products in development with a current total brand market value of more than $75Bil in worldwide sales.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!